Cargando…
Identification of potential pan-coronavirus therapies using a computational drug repurposing platform
In the past 20 years, there have been several infectious disease outbreaks in humans for which the causative agent has been a zoonotic coronavirus. Novel infectious disease outbreaks, as illustrated by the current coronavirus disease 2019 (COVID-19) pandemic, demand a rapid response in terms of iden...
Autores principales: | Hwang, Woochang, Han, Namshik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577587/ https://www.ncbi.nlm.nih.gov/pubmed/34767922 http://dx.doi.org/10.1016/j.ymeth.2021.11.002 |
Ejemplares similares
-
Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens
por: Yim, Soorin, et al.
Publicado: (2022) -
Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies
por: Han, Namshik, et al.
Publicado: (2021) -
Repurposing dyphylline as a pan-coronavirus antiviral therapy
por: Wang, Yining, et al.
Publicado: (2022) -
dialogi: Utilising NLP With Chemical and Disease Similarities to Drive the Identification of Drug-Induced Liver Injury Literature
por: Katritsis, Nicholas M., et al.
Publicado: (2022) -
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
por: Hwang, Woochang, et al.
Publicado: (2021)